• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

输血选择:改善治疗效果并降低成本。

Blood transfusion options: improving outcomes and reducing costs.

作者信息

AuBuchon J P

机构信息

Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

出版信息

Arch Pathol Lab Med. 1997 Jan;121(1):40-7.

PMID:9111091
Abstract

OBJECTIVE

To identify means of improving provision of transfusion services to patients while reducing hospital costs, focusing on the practice of transfusion medicine and laboratory operations in a hospital.

DATA SOURCES

English language literature, 1990 to present.

STUDY SELECTION

Case reports, controlled trials, and reviews.

CONCLUSIONS

Owing to fixed reimbursements, hospitals are seeking ways to reduce operational costs while maintaining patient care standards. In transfusion medicine, this can be accomplished through recognition of direct and indirect costs of transfusion, careful examination of transfusion criteria, and selection of laboratory procedures that truly add to patient safety.

摘要

目的

确定在降低医院成本的同时改善患者输血服务的方法,重点关注医院输血医学实践和实验室操作。

数据来源

1990年至今的英文文献。

研究选择

病例报告、对照试验和综述。

结论

由于固定报销制度,医院在维持患者护理标准的同时,正在寻求降低运营成本的方法。在输血医学中,这可以通过认识输血的直接和间接成本、仔细检查输血标准以及选择真正能提高患者安全性的实验室程序来实现。

相似文献

1
Blood transfusion options: improving outcomes and reducing costs.输血选择:改善治疗效果并降低成本。
Arch Pathol Lab Med. 1997 Jan;121(1):40-7.
2
Reengineering transfusion and cellular therapy processes hospitalwide: ensuring the safe utilization of blood products.在全院范围内重新设计输血和细胞治疗流程:确保安全使用血液制品。
Transfusion. 2005 Oct;45(4 Suppl):159S-71S. doi: 10.1111/j.1537-2995.2005.00617.x.
3
Blood management: a model of excellence.血液管理:卓越典范
Clin Leadersh Manag Rev. 2007 Mar 28;21(2):E2.
4
Role of quality improvement in prevention of inappropriate transfusions.质量改进在预防不适当输血中的作用。
Qual Manag Health Care. 2011 Oct-Dec;20(4):298-310. doi: 10.1097/QMH.0b013e3182315d22.
5
Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: an analysis of two prospective clinical trials.患有严重消化性溃疡出血和非出血性可见血管的个体的临床和经济结果:两项前瞻性临床试验的分析
Am J Gastroenterol. 1998 Nov;93(11):2047-56. doi: 10.1111/j.1572-0241.1998.00590.x.
6
Point-of-care testing: an introduction.即时检验:简介
Ann Pharmacother. 2004 Jan;38(1):119-25. doi: 10.1345/aph.1D212.
7
Cost implications of post-surgical morbidity following blood transfusion in cancer patients undergoing elective colorectal resection: an evaluation in the US hospital setting.择期结直肠癌切除术后输血的癌症患者术后发病的成本影响:美国医院环境下的评估
Curr Med Res Opin. 2005 Mar;21(3):447-55. doi: 10.1185/030079905X30734.
8
Blood and marrow transplantation compensation: perspective in payer and provider relations.血液与骨髓移植补偿:支付方与供应方关系的视角
Biol Blood Marrow Transplant. 2004 Jul;10(7):427-32. doi: 10.1016/j.bbmt.2004.03.004.
9
Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications.用于严重出血的温热新鲜全血输注:美国军方及潜在的民用应用
Crit Care Med. 2008 Jul;36(7 Suppl):S340-5. doi: 10.1097/CCM.0b013e31817e2ef9.
10
[Estimating the microcosts of blood transfusion for hemato-oncological patients].
Acta Med Port. 2008 Nov-Dec;21(6):575-80. Epub 2009 Mar 24.